| Application no. and date | 17791737.4 (espacenet) (Federated) (European Patent Register), 20170928 | | Patent/reg. no. and date | DK/EP 3519419, 20200527 | | Publication date | 20190807 | | Priority no. and date | US 201662401022 P, 20160928 | | EP pub. no. and date |
EP 3519419 20190807 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | V48423DK00 | | Inventor | KOCH, Guido, Novartis Pharma AG
Postfach
4002 Basel, CH,
CASAREZ, Anthony, Novartis Institutes for BioMedical Research Inc.
5300 Chiron Way
Emeryville, California 94608, US,
FUREGATI, Markus, Novartis Pharma AG
Postfach
4002 Basel, CH,
OSSOLA, Flavio, Novartis Pharma AG
Postfach
4002 Basel, CH,
LIN, Xiaodong, Novartis Institutes for BioMedical Research, Inc.
5300 Chiron Way
Emeryville, California 94608, US,
RECK, Folkert, Novartis Institutes for BioMedical Research, Inc.
5300 Chiron Way
Emeryville, California 94608, US,
SIMMONS, Robert Lowell, Novartis Institutes for BioMedical Research, Inc.
5300 Chiron Way
Emeryville, California 94608, US,
ZHU, Qingming, Novartis Institutes for BioMedical Research, Inc.
5300 Chiron Way
Emeryville, California 94608, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/407 (2006.01) , A61K 31/427 (2006.01) , A61K 31/431 (2006.01) , A61K 31/4545 (2006.01) , A61K 31/496 (2006.01) , A61K 31/5025 (2006.01) , A61K 31/546 (2006.01) , A61K 31/551 (2006.01) , A61K 45/06 (2006.01) , A61P 31/04 (2006.01) , C07D 471/18 (2006.01) | | Title | BETA-LACTAMASE-INHIBITORER | | Int. application no. | IB2017055973 | | Int. publication no. | WO2018060926 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
